BCL-5

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameBCL-5
Drug Alias NameN/A
ClassificationNatural product/Extract
Mechanisms of ActionGlucosidases inhibitors
TargetsGlucosidases
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A